Cite
HARVARD Citation
Babagana, M. et al. (2020). The role of polo‐like kinase 3 in the response of BRAF‐mutant cells to targeted anticancer therapies. Molecular carcinogenesis. 59 (1), pp. 5-14. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Babagana, M. et al. (2020). The role of polo‐like kinase 3 in the response of BRAF‐mutant cells to targeted anticancer therapies. Molecular carcinogenesis. 59 (1), pp. 5-14. [Online].